Video: What is multiple myeloma?
Multiple myeloma is a relatively uncommon form of blood cancer that affects less than 1% of the U.S. population, according the American Cancer Society.
Mar 13, 2023
0
41
Immune System Diseases: News and Research on Multiple Myeloma
MeSH tree: C20.683.780.650
Scientists discover new lead in hunt for myeloma drug
A molecule involved in fat transport and metabolism is key to the progression of the malignant blood cancer multiple myeloma, researchers report today in eLife.
Mar 7, 2023
0
58
Using donor CAR T cells shows promise in treating myeloma patients in phase I trial
A team of medical specialists working at Memorial Sloan Kettering Cancer Center in New York has found that donated white blood cells can be used effectively as part of CAR T cell therapy to treat myeloma patients.
New findings on therapy-related myeloid cancers
Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have illuminated how treatments for multiple myeloma and other aggressive blood cancers can lead to future malignancies, ...
Jan 26, 2023
0
203
Body mass index tied to multiple myeloma survival
Underweight and severe obesity are associated with decreased survival in patients with multiple myeloma (MM), according to a study published online Jan. 12 in the Blood Cancer Journal.
Jan 23, 2023
0
84
Inflammatory-nutritional score helps predict survival in new multiple myeloma
For patients with newly diagnosed multiple myeloma (NDMM), a nomogram based on the inflammatory-nutritional score (INS) may help to predict survival, according to a study published online Jan. 5 in the Journal of Inflammation ...
Jan 20, 2023
0
64
Mass spectrometry can monitor treatment response in multiple myeloma
For patients with newly diagnosed multiple myeloma (MM), mass spectrometry (MS) can monitor treatment response, according to a study published online Jan. 4 in Blood Cancer Journal.
Jan 19, 2023
0
48
Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001
A new research paper titled "Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001" has been published in Oncotarget.
Jan 17, 2023
0
58
Triple-drug therapy for post-transplant management of multiple myeloma
Researchers from the University of Chicago Medicine Comprehensive Cancer Center and colleagues in Poland report promising results from their ongoing ATLAS trial, published on January 12, 2023 in the journal Lancet Oncology.
Jan 13, 2023
0
56
COVID-19 vaccination shown to protect people with blood cancer
People suffering from blood cancer often have a weak immune system, putting them at higher risk of falling seriously ill with COVID-19. Some cancer therapies, moreover, result in these patients forming few or no antibodies ...
Dec 22, 2022
3
69
